NP / PA
Chaluparambil, Ansela
Chaluparambil, Ansela was paid $74K by Medicaid between Sep 2020 and Dec 2024, across 21 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 40% of everything it billed.
33Billing provider infoCHALUPARAMBIL, ANSELA
PASADENA, TX 77504
PASADENA, TX 77504
33aNPI1548817919assigned 08/21/2019
33bProvider typeFamily Nurse Practitioner
28Total paid$74K
24GClaims3,279
24DCodes billed21
24AFirst – last monthSep 2020 – Dec 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Texas
Rank by total paid#94 of 344
Median peer was paid$14K
This provider vs. median5.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 130 | $3K | |
| 2021 | 52 | $1K | |
| 2022 | 823 | $19K | |
| 2023 | 485 | $10K | |
| 2024incomplete | 1,789 | $42K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 40% | 802 | 777 | $30K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 188 | 185 | $10K |
| S8301 | Infection control supplies, not otherwise specified | 9.1% | 452 | 439 | $7K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 5.9% | 193 | 188 | $4K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.8% | 53 | 52 | $4K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.3% | 316 | 152 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5.2% | 471 | 236 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4.3% | 391 | 379 | $3K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.2% | 26 | 26 | $2K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.2% | 32 | 31 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.4% | 45 | 42 | $1K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 27 | 26 | $675.26 |
9 more codes
| 99429 | <1% | 14 | $430.44 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 51 | $427.50 |
| 97803 | <1% | 43 | $388.80 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 30 | $312.87 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 16 | $155.70 |
| 90461 | <1% | 20 | $126.90 | |
| 96160 | <1% | 39 | $73.16 | |
| 90686 | 0% | 31 | $0.00 | |
| 96127 | 0% | 39 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.